Diurnal variation in fasting plasma glucose: Implications for diagnosis of diabetes in patients examined in the afternoon

JAMA

Volumn 284, Issue 24, 2000, Pages 3157-3159

  Troisi, Rebecca J ^a   Cowie, Catherine C ^b   Harris, Maureen I ^b  

^a SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CIRCADIAN RHYTHM; DATA ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034722953     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.24.3157     Document Type: Article

References (13)

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
2. The "dawn phenomenon": A common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus
3. Demonstration of a dawn phenomenon in normal human volunteers
4. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults
5. Fasting early morning rise in peripheral insulin: Evidence of the dawn phenomenon in nondiabetes
6. Demonstration of a dawn phenomenon in normal adolescents
7. Absence of the dawn phenomenon in normal subjects
8. Failure to detect the "dawn phenomenon" in nondiabetic subjects with markedly different patterns of nocturnal growth hormone secretion
9. Absence of dawn phenomenon in normal children and adolescents
10. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus: Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion
11. Circadian variation of insulin requirement in insulin dependent diabetes mellitus: The relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia
12. The roles of time of day and sleep quality in modulating glucose regulation: Clinical implications
13. Roles of circadian rhythmicity and sleep in human glucose regulation